Solventum management check
SOLV · Health Care · Health Care Technology · CEO Bryan C. Hanson
Filings as of
3 good · 3 to watch · 0 flagged, across the seven questions below.
- Good
Have owners done well?
Beat its chosen peers$100 invested at the start of fiscal 2024 grew to $115, against $109 for the peer group the company picked itself.
- n/a
Does pay follow performance?
Not enough dataToo few years of pay and return figures to compare.
- Watch
What does the CEO cost owners?
1.3% of net income$20.1m of reported pay in fiscal 2025, against $1.6bn of net income.
- Watch
Do they own the stock?
CEO stake ≈ 1.0 years of payThe CEO holds 211,983 shares, directly or through trusts (unvested awards not counted): about 1.0 years of pay. No open-market insider buying or selling in the last six months.
- Watch
Are owners being diluted?
Share count growingDiluted shares changed +0.7% a year over the last three fiscal years. Stock-based pay was 1.9% of revenue in the latest year.
- Good
Is leadership stable?
8 leadership filings in 3 yearsCEO in the pay table: Bryan C. Hanson. 8 filings under 8-K item 5.02 (officers or directors leaving or joining, or new pay arrangements) in the last 3 years.
- Good
Are the books clean?
No red flags on fileNo restatements, auditor changes or late filings since 2023.
Against the S&P 500
Each check's score (0–100) and how it compares: the share of ranked S&P 500 companies it matches or beats, and the median in Health Care.
| Check | Score | At or above | Sector median |
|---|---|---|---|
| Owner returns | 57 | 26 | |
| Pay for performance | — | — | 85 |
| CEO cost | 41 | 44 | |
| Skin in the game | 34 | 46 | |
| Dilution | 41 | 68 | |
| Stable leadership | 85 | 70 | |
| Clean books | 100 | 100 |
Closest peers
Others in Health Care Technology, by management score. Solventum is 39th of 60 in its sector.
- 277VEEVVeeva Systems63
- 321STESteris60
- 323MRKMerck & Co.60
- 325SOLVSolventum59
- 331ALGNAlign Technology59
- 333COOCooper Companies (The)59
Pay versus performance
From the proxy statement filed March 27, 2026. "Actually paid" values stock awards at the share price, so it rises and falls with the stock.
| Fiscal year | CEO | CEO pay | Actually paid | Other executives (avg) | $100 became | Peers | Net income |
|---|---|---|---|---|---|---|---|
| 2025 | Bryan C. Hanson | $20.1m | $40.0m | $5.1m | $115 | $109 | $1.6bn |
| 2024 | — | $40.0m | $40.2m | $8.5m | $96 | $95 | $479.0m |
The board says pay is tied most to Constant Currency Revenue. Its other key measures: Adjusted EPS, Adjusted Operating Income, Free Cash Flow, Relative TSR.
Insiders and the CEO's stake
Bryan C Hanson (Chief Executive Officer) held 211,983 shares directly after their latest Form 4 on Sep 1, 2026, roughly $19.3m at that filing's price.
No open-market insider buying or selling in the last six months.
Leadership and governance on file
- Jul 20, 2026Leadership change8-K 5.02
- May 27, 2026Leadership change8-K 5.02
- Mar 24, 2026Leadership change8-K 5.02
- Oct 21, 2025Leadership change8-K 5.02
- Nov 5, 2024Leadership change8-K 5.02
- May 17, 2024Leadership change8-K 5.02
- Apr 16, 2024Leadership change8-K 5.02
- Apr 4, 2024Leadership change8-K 5.02
Latest shareholder vote results: May 20, 2026, including the say-on-pay vote.
Where the money went
Over 2021–2025: $0 returned to owners in buybacks and dividends, 0% of net income, and $349.0m of pay in stock.
| Fiscal year | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | — | $8.1bn | $8.2bn | $8.3bn | $8.3bn |
| Net income | — | $1.3bn | $1.3bn | $479.0m | $1.6bn |
| Stock-based pay | — | $37.0m | $39.0m | $112.0m | $161.0m |
| Buybacks | — | — | — | — | — |
| Dividends | — | — | — | — | — |
| Diluted shares | — | 173m | 173m | 174m | 175m |
Educational only, not investment advice. Figures are as filed with the SEC: pay from the proxy's pay-versus-performance table, capital allocation from 10-K XBRL data, insider trades from Form 4s over the last six months, events from the last 5 years of filings. The peer group is the one the company chose. See the method.